Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Tesaro makes its case for a clean sweep with niraparib - and shares soar again
9 years ago
R&D
Kite touts 12-month remission data from tiny CAR-T study; Ironwood exec dies in bike accident
9 years ago
News Briefing
Thumbs Up/Thumbs Down: Major insurer delivers a bad blow to Duchenne families
9 years ago
Bioregnum
Opinion
Clovis shares tank after investors size up the disappointing data on rucaparib
9 years ago
R&D
Updated Incyte combo data for epacadostat/Keytruda look promising
9 years ago
R&D
Lethal experimental cancer drug from Hanmi, Boehringer killed three patients — report
9 years ago
R&D
Pfizer plots a big move (but it's not going very far)
9 years ago
Pharma
Medicxi launches a diabetes upstart with $11M; Arrowhead partners on hep B; Immunotherapy startup gains $12.2M round
9 years ago
News Briefing
Reuters probe spotlights a conflict of interest between biotech investor F-Prime and giant Fidelity
9 years ago
Financing
Teva hands Celltrion $160M to grab US rights on two biosimilars of Roche blockbusters
9 years ago
R&D
Pharma
Pilot project provides a snapshot of effectiveness of Pfizer’s PARP contender talazoparib
9 years ago
R&D
Feds help NewLink, Merck out with some added cash for Ebola vaccine
9 years ago
R&D
Pharma
Alnylam shares crater after trial deaths force investigators to scrap PhIII RNAi drug
9 years ago
R&D
Can We Conquer All Diseases By The End Of The Century? An Interview with Chan Zuckerberg's Cori Bargmann.
9 years ago
People
UK startup tackles hot neoantigen field in cancer drugs
9 years ago
Financing
Startups
Biotech billionaire backs a food allergy/nutrition startup; Editas recruits a CMO
9 years ago
News Briefing
André Choulika on gene editing: "If you marry yourself to a technology, you're doomed."
9 years ago
People
AstraZeneca jettisons another drug, this time grabbing $30M for out-licensing deal
9 years ago
R&D
Hold the applause: Big Pharma has little to brag about regarding 2016 R&D productivity
9 years ago
R&D
Pharma
Novartis unveils a new global R&D structure, creating centers in Cambridge, MA and Basel
9 years ago
R&D
Pharma
Novartis is uprooting another research group in ongoing global reorganization
9 years ago
R&D
Pharma
Samsung BioEpis pitches Herceptin biosimilar as parent company hunts $2B IPO; Chiasma CEO is out
9 years ago
News Briefing
Hustling to capture top frontline NSCLC status, Roche scores a ‘breakthrough’ on Alecensa
9 years ago
R&D
Amgen joins a marquee list of partners jumping on Nuevolution’s discovery platform
9 years ago
R&D
Pharma
First page
Previous page
1160
1161
1162
1163
1164
1165
1166
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit